Notch receptors have been implicated as oncogenic drivers in a number of different human cancers, including T-ALL, which shows increased Notch1 activity in about 60% of cases, due to activating Notch1 mutations or alterations in the FBXW7 gene2,3. Here, NOTCH1 is linked to acute lymphoblastic leukemia.